Removal of physiologic corticosteroid doses results in HLA antibody appearance and allograft dysfunction in patients transplanted under a clonal deletion protocol.

Clinical transplants

Volumn , Issue , 2009, Pages 281-293

  Everly, Matthew J ^a   Jahr, Fay ^b   Kaneku, Hugo ^b   Trivedi, Hargovind L ^b   Terasaki, Paul I ^b  

^a One Lambda Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BORONIC ACID DERIVATIVE; BORTEZOMIB; CORTICOSTEROID; CREATININE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; BIOPSY; BLOOD; FOLLOW UP; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INDIA; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; LIVING DONOR; METHODOLOGY; PATHOLOGY;

ADRENAL CORTEX HORMONES; ADULT; BIOPSY; BORONIC ACIDS; CLONAL DELETION; CREATININE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIA; KIDNEY TRANSPLANTATION; LIVING DONORS; PREDNISONE; PROTEASE INHIBITORS; PYRAZINES; YOUNG ADULT;

EID: 77954598376     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)